Follow
Ning Wei
Ning Wei
Albert Einstein College of Medicine
Verified email at einsteinmed.edu - Homepage
Title
Cited by
Cited by
Year
Esculetin, a coumarin derivative, exerts in vitro and in vivo antiproliferative activity against hepatocellular carcinoma by initiating a mitochondrial-dependent apoptosis pathway
J Wang, ML Lu, HL Dai, SP Zhang, HX Wang, N Wei
Brazilian Journal of Medical and Biological Research 48, 245-253, 2014
832014
Targeting colon cancer with the novel STAT3 inhibitor bruceantinol
N Wei, J Li, C Fang, J Chang, V Xirou, NK Syrigos, BJ Marks, E Chu, ...
Oncogene 38 (10), 1676-1687, 2019
762019
Protein kinase d as a potential chemotherapeutic target for colorectal cancer
N Wei, E Chu, P Wipf, JC Schmitz
Molecular cancer therapeutics 13 (5), 1130-1141, 2014
712014
Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway
D Dong, Z Mu, N Wei, M Sun, W Wang, N Xin, Y Shao, C Zhao
Biomedicine & Pharmacotherapy 111, 917-925, 2019
642019
H1, a novel derivative of tetrandrine reverse P-glycoprotein-mediated multidrug resistance by inhibiting transport function and expression of P-glycoprotein
N Wei, H Sun, F Wang, G Liu
Cancer chemotherapy and pharmacology 67, 1017-1025, 2011
582011
H1, a derivative of Tetrandrine, exerts anti-MDR activity by initiating intrinsic apoptosis pathway and inhibiting the activation of Erk1/2 and Akt1/2
N Wei, GT Liu, XG Chen, Q Liu, FP Wang, H Sun
Biochemical pharmacology 82 (11), 1593-1603, 2011
512011
Protective effects of BAY 73-6691, a selective inhibitor of phosphodiesterase 9, on amyloid-β peptides-induced oxidative stress in in-vivo and in-vitro models of Alzheimer's …
J Li, CN Liu, N Wei, XD Li, YY Liu, R Yang, YJ Jia
Brain research 1642, 327-335, 2016
372016
The cytotoxic effects of regorafenib in combination with protein kinase D inhibition in human colorectal cancer cells
N Wei, E Chu, S Wu, P Wipf, JC Schmitz
Oncotarget 6 (7), 4745-56, 2015
272015
HDAC10 is positively associated with PD-L1 expression and poor prognosis in patients with NSCLC
X Liu, Y Wang, R Zhang, T Jin, L Qu, Q Jin, J Zheng, J Sun, Z Wu, L Wang, ...
Frontiers in oncology 10, 485, 2020
262020
DNA damage and apoptosis induced by a potent orally podophyllotoxin derivative in breast cancer
Y Wang, H Sun, Z Xiao, G Zhang, D Zhang, X Bao, F Li, S Wu, Y Gao, ...
Cell Communication and Signaling 16, 1-13, 2018
262018
XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma
Y Wang, H Sun, Z Xiao, D Zhang, X Bao, N Wei
Scientific reports 7 (1), 9989, 2017
202017
Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1, a derivative of tetrandrine
YX Zhang, XM Liu, J Wang, J Li, Y Liu, H Zhang, XW Yu, N Wei
Cancer Biology & Therapy 16 (6), 965-75, 2015
202015
MiR-155 inhibits transformation of macrophages into foam cells via regulating CEH expression
F Zhang, J Zhao, D Sun, N Wei
Biomedicine & Pharmacotherapy 104, 645-651, 2018
192018
Silencing of lncRNA AFAP1-AS1 inhibits cell growth and metastasis in clear cell renal cell carcinoma
Z Mu, D Dong, N Wei, M Sun, W Wang, Y Shao, J Gao, P Yin, C Zhao
Oncology research 27 (6), 653, 2019
162019
Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations
R Pal, N Wei, N Song, S Wu, RS Kim, Y Wang, PG Gavin, PC Lucas, ...
PloS one 13 (8), e0200836, 2018
152018
Bis-cyclopropane analog of disorazole C1 is a microtubule-destabilizing agent active in ABCB1-overexpressing human colon cancer cells
S Wu, Z Guo, CD Hopkins, N Wei, E Chu, P Wipf, JC Schmitz
Oncotarget 6 (38), 40866, 2015
152015
Overview on Anticancer Agents from Meretrix Meretrix
N Wei, XK Lin, RL Niu, HY Li
Food and Drug 9 (11), 63-65, 2007
152007
Advances in the targeting ATP-binding cassette transporters to overcome tumor multi-drug resistance
N Wei, H Sun, GT Liu
Yao xue xue bao= Acta Pharmaceutica Sinica 45 (10), 1205-1211, 2010
122010
H1, a derivative of tetrandrine, enhances the efficacy of 5-FU in Bel7402/5-FU cells via suppressing STAT3/MCL-1 and inducing PUMA
F Li, J Wang, N Wu, H Zhang, Z Li, N Wei
Biochemical and Biophysical Research Communications 520 (1), 93-98, 2019
92019
Emerging roles of Aurora-A kinase in cancer therapy resistance
D Zheng, J Li, H Yan, G Zhang, W Li, E Chu, N Wei
Acta Pharmaceutica Sinica B, 2023
72023
The system can't perform the operation now. Try again later.
Articles 1–20